AnalystsDaniel MarkowitzDaniel Markowitz's Stock Forecasts
AnalystsDaniel Markowitz
Analyst Ranking
Top 39%
#1944 out of 5069 analysts
Average Return
+5.3%
Win Rate
67%8 out of 12
Risk vs Reward
Poor
Good
Daniel Markowitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Natera IncNTRA | +31.66% | $138.00 | $181.69 | 2025-07-28 - 2025-10-17 | Buy |
Repligen CorpRGEN | +21.17% | $125.94 | $152.60 | 2025-09-22 - 2025-10-17 | Buy |
West Pharmaceutical Services IncWST | +15.41% | $234.47 | $270.60 | 2025-03-18 - 2025-10-17 | Buy |
Repligen CorpRGEN | +4.57% | $145.93 | $152.60 | 2025-10-07 - 2025-10-17 | Buy |
Bio Techne CorpTECH | +4.51% | $59.19 | $61.86 | 2025-10-07 - 2025-10-17 | Buy |
Daniel Markowitz Analyst Color
Get additional color on Daniel Markowitz's coverage of popular stocks
Daniel Markowitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bio Techne CorpTECH | 2 | Buy | $72.00 | +16.39% | Maintains | 12 days ago |
Repligen CorpRGEN | 4 | Buy | $175.00 | +14.68% | Maintains | 12 days ago |
Inspire Medical Systems IncINSP | 2 | Buy | $125.00 | +60.24% | Maintains | 12 days ago |
Guardant Health IncGH | 1 | Buy | $68.00 | +3.88% | Maintains | 12 days ago |
Rambus IncRMBS | 1 | Buy | $114.00 | +18.43% | Maintains | a month ago |
Transmedics Group IncTMDX | 1 | Buy | $155.00 | +31.77% | Initiates Coverage On | a month ago |
Natera IncNTRA | 1 | Buy | $170.00 | -6.43% | Initiates Coverage On | 3 months ago |
West Pharmaceutical Services IncWST | 2 | Buy | $350.00 | +29.34% | Maintains | 3 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.